Validation of i-ROP DL to Detect More Than Mild Retinopathy of Prematurity and a Multi-Reader Multi-Case Controlled Clinical Trial to Evaluate the Comparative Accuracy of Diagnosing Plus Disease of Premature Infants With or Without the Aid of the i-ROP DL in Telemedicine Setting

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of the pivotal reader study is to assess the readers' accuracy in diagnosing plus disease versus no plus or pre-plus disease with or without the aid of the i-ROP DL. Ophthalmologists' performance metrics for the following modalities will be evaluated: * Standard evaluation following the standard of care process (without i-ROP DL) * Evaluation following the standard of care process with the aid of the i-ROP DL (with i-ROP DL) This retrospective multi-reader multi-case (MRMC) study will have an enriched sample of approximately 300 eye cases (1 study eye per subject): 60 plus cases, 120 pre-plus cases and 120 no plus cases. Enrichment is with respect to proportions of plus cases and pre-plus cases. The primary objective of this study is to evaluate whether the area under the receiver operating characteristic (ROC) curve (AUC) based on probability scores of plus disease statistically significantly non-inferior or superior with the aid of the i-ROP DL versus without the aid of the i-ROP DL. Multiple secondary endpoints are outlined in the next section.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 80
Healthy Volunteers: t
View:

• U.S. board-eligible/board-certified and licensed Medical Doctor, Doctor of Ophthalmology. (American Board of Ophthalmology or equivalent certification)

• Signed reader study agreement.

• Signed informed consent.

• Successful training on the study protocol and the use of the study software

Locations
United States
Oregon
Oregon Health and Sciences University
RECRUITING
Portland
Contact Information
Primary
Karyn E Jonas, MSN
karyn@siloamvision.com
5618182161
Backup
Susan Ostmo, MS
ostmo@ohsu.edu
Time Frame
Start Date: 2024-06-25
Estimated Completion Date: 2025-03-01
Participants
Target number of participants: 16
Treatments
Experimental: Reader Study
Vascular Severity Score Provided on second reading
Sponsors
Leads: Siloam Vision
Collaborators: National Eye Institute (NEI)

This content was sourced from clinicaltrials.gov